2nd for the Department of Genetics, Genomics and Cancer Sciences' research in REF2021

We are delighted with our recent performance in the 2021 Research Excellence Framework (REF2021), in which we placed second in the UK for our overall research quality (GPA) out of 31 submissions for UoA 1 Clinical Medicine and 20th in the UK for UoA 5 Biological Sciences (according to analysis by the Times Higher Education). The majority of staff from Genetics, Genomics and Cancer Sciences were submitted to these units.

In addition:

• 90% of the real-world impact of research in UoA 5 Biological Sciences was judged to be ’outstanding’ (4*) – the top score in the UK for this measure
• 95% of the research in UoA 1 Clinical Medicine was judged to be ‘world-leading’ (4*) or ‘internationally excellent’ (3*)
• Leicester had the highest proportion (62%) of research outputs judged to be ‘world leading’ in UoA 1 Clinical Medicine

The Research Excellence Framework is the UK’s system for assessing the quality of research in UK higher education institutions. REF2021 results were announced on Thursday 12 May 2022, you can find more details on the University’s overall performance.

Times Higher Education (THE) analyse the results of REF2021 and rank each institution according to their performance.